Biden’s Medicare Chief Is Crafting How Program Will Negotiate Drug Prices

A top Biden administration official planning Medicare’s first drug-price negotiations is talking directly with pharma executives and consulting with other agencies that buy medications for the government to begin hammering out details of the new policy.

Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure didn’t name which chief executive officers she’s met with but said the conversations have been collaborative. Her comments contrast with the drug industry’s confrontational public stance against the policy.